HELLENIC PASTEUR INSTITUTE
Desconocido
EXPAND-EV: EXPANDing the value of Extracellular Vesicles as carriers of biomarker and therapy in precision heal...
Extracellular vesicles (EVs) have been identified as important signaling mediators in a myriad of physiological and pathological processes....
2024-08-19 - 2028-12-31 | Financiado
2024-08-19 - 2028-12-31 | Financiado
ELIXIR-STEERS: ELIXIR STEERS
HELLENIC PASTEUR INSTITUTE
participó en un
HORIZON EUROPE:
HORIZON-INFRA-2023-DEV-01
ELIXIR unites Europe’s leading life science organisations in managing and safeguarding the increasing volume of data being generated by publ...
2023-11-03 - 2027-01-31 | Financiado
2023-11-03 - 2027-01-31 | Financiado
LEAPS: Integrating Multi-Disciplinary Expertise in a Learning and Adaptive European Pandemic Preparedness S...
HELLENIC PASTEUR INSTITUTE
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2022-DISEASE-07
The COVID-19 pandemic has exposed a global need for accelerating research, improving surveillance, and efficiently developing countermeasure...
2023-10-09 - 2027-09-30 | Financiado
2023-10-09 - 2027-09-30 | Financiado
IgG4-TREAT: Systematic study of IgG4-autoimmune diseases to develop new treatment strategies
HELLENIC PASTEUR INSTITUTE
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2022-DN-01
IgG4-autoimmune diseases (IgG4-AID) are rare but collectively correspond to a significant group of devastating diseases affecting
many diffe...
2023-07-07 - 2027-08-31 | Financiado
2023-07-07 - 2027-08-31 | Financiado
EVA-GLOBAL: European Virus Archive GLOBAL
HELLENIC PASTEUR INSTITUTE
participó en un
H2020:
H2020-INFRAIA-2018-2020
EVA-GLOBAL gathers 38 academic institutions at the forefront of human, animal and plant research in Virology, associated with key Non-Govern...
2019-12-16 - 2024-09-30 | Financiado
2019-12-16 - 2024-09-30 | Financiado
ERINHA2: European Research Infrastructure on Highly Pathogenic Agents 2
HELLENIC PASTEUR INSTITUTE
participó en un
H2020:
H2020-INFRADEV-2014-2015
ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administr...
2015-10-08 - 2017-06-30 | Financiado
2015-10-08 - 2017-06-30 | Financiado
NEUROSIGN: Development of a Center of Excellence in Neurosignalling
HELLENIC PASTEUR INSTITUTE
tramitó un
FP7:
The goal of NeuroSign is to create a national Centre of Excellence for the study of Neurosignalling during nervous system function and dysfu...
Financiado
Financiado
NEUROCYPRES: Neurotransmitter Cys loop receptors structure function and disease
HELLENIC PASTEUR INSTITUTE
participó en un
FP7:
Cys-loop receptors (CLRs) form a superfamily of structurally related neurotransmitter-gated ion channels, comprising nicotinic acetylcholine...
Financiado
Financiado
CHEMBIOFIGHT: Exploring Chemical Biodiversity with Innovative Approaches for Fighting Chagas and Leismaniasis
HELLENIC PASTEUR INSTITUTE
participó en un
FP7:
The ChemBioFight project aims towards the exploration of natural resources to the discovery of bioactive therapeutic molecules against leish...
Financiado
Financiado
CYCLON HIT: NANOCARRIERS FOR THE DELIVERY OF ANTIMICROBIAL AGENTS TO FIGHT RESISTANCE MECHANISMS
HELLENIC PASTEUR INSTITUTE
participó en un
FP7:
The worldwide spread of antibiotic-resistant microorganisms can be viewed as an ecological consequence of the systematic use of antimicrobia...
Financiado
Financiado
FIGHT-MG: Myasthenias a group of immune mediated neurological diseases from etiology to therapy
HELLENIC PASTEUR INSTITUTE
participó en un
FP7:
Myasthenia Gravis (MG) is a heterogeneous rare autoimmune neurological disease affecting the neuromuscular junction (NMJ). The molecular eve...
Financiado
Financiado
ERINHA: European Research Infrastructure on Highly Pathogenic Agents
HELLENIC PASTEUR INSTITUTE
participó en un
FP7:
In the context of the emerging and re-emerging infectious diseases involving highly pathogenic microorganisms, European countries have to be...
Financiado
Financiado
* No se disponen de datos de la empresa actual.